Search Results
May 27, 2026, 13:44 ET Human Longevity's Launched New Entity Human Life Foundation Models, Inc. and Insilico Medicine Collaborates to Build the First Foundation Model for Longevity Science
HLFM will combine Human Longevity's unique de-identified multi-omic and clinical datasets with Insilico Medicine's cutting-edge artificial intelligence technologies. The goal of HLFM is to build one of the world's most
More news about: Human Longevity, Inc.
May 26, 2026, 09:41 ET Insilico Medicine and Human Longevity Announce Collaboration to Co-Develop Industry-First AI Foundation Model for Longevity Science
jointly developed model.Human Life Foundation Models will integrate these tools and capabilities with Human Longevity's unique, de-identified multi-omic and clinical datasets to build advanced multimodal AI models. Drawing from over a decade of research, Human Longevity has curated one of the world's
More news about: Insilico Medicine
May 22, 2026, 08:30 ET Caris Life Sciences to Present 32 Studies at ASCO 2026 Highlighting Advances in Multi-omic Biomarker Research and Real-World Evidence
analyses and multi-omic biomarker investigations focused on immuno-oncology, tumor microenvironment characterization, and predicting treatment response and resistance."Caris is proud to collaborate with leading academic and clinical institutions to advance large-scale, multi-omic research and real-world
More news about: Caris Life Sciences
May 14, 2026, 11:48 ET Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA
precision oncology company focused on developing and delivering advanced cancer diagnostics, including non-invasive liquid biopsy and tissue-based multi-omic solutions, for early detection, treatment selection and cancer monitoring. With UKAS-, CAP- and CLIA-accredited laboratories and a presence across the
More news about: Datar Cancer Genetics
May 14, 2026, 11:39 ET Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA
precision oncology company focused on developing and delivering advanced cancer diagnostics, including non-invasive liquid biopsy and tissue-based multi-omic solutions, for early detection, treatment selection and cancer monitoring. With UKAS-, CAP- and CLIA-accredited laboratories and a presence across the
More news about: Datar Cancer Genetics
May 13, 2026, 12:16 ET Non-Animal Alternative Testing Market Size to Reach $29.4 Billion by 2030, Globally, at 13.5% CAGR: Allied Market Research
Non-Animal Alternative Testing Market by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, and Omic Technology), Method (Cellular Assay, Biochemical Assay, In Silico, and Ex Vivo), and End User (Pharmaceutical Industry, Cosmetics & Household Products,
More news about: Allied Market Research
May 12, 2026, 03:04 ET ACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers
Sleeping Beauty-engineered anti-CD19 CAR T cells, achieving an 83% complete remission rate with long-term persistence. She also highlighted how multi-omic analyses identified tumor microenvironment immune suppression as a key barrier, and introduced a modular AdFITC-CAR T platform designed to enable flexible,
More news about: ACROBiosystems Group
May 07, 2026, 02:24 ET Photocure ASA: Results for the first quarter of 2026
we made a targeted 3.0 million dollar minority investment in Vesica Health, a company within precision diagnostics, developing and launching a multi-omic urine biomarker test for early detection of bladder cancer with best-in-class performance. Our initiatives in flexible cystoscopy with Richard Wolf,
More news about: Photocure
May 07, 2026, 02:13 ET Photocure ASA: Results for the first quarter of 2026
we made a targeted 3.0 million dollar minority investment in Vesica Health, a company within precision diagnostics, developing and launching a multi-omic urine biomarker test for early detection of bladder cancer with best-in-class performance. Our initiatives in flexible cystoscopy with Richard Wolf,
More news about: Photocure
May 05, 2026, 04:03 ET BC Platforms signs Strategic Collaboration Agreement with AWS to accelerate healthcare and life sciences innovation
available in BC Mosaic include:Scalable, cloud-native infrastructure for large multi-modal datasets — As clinical, multi-omic, and medical imaging datasets continue to grow, AWS infrastructure provides the necessary storage and compute capacity while BC Mosaic ensures data
More news about: BC Platforms
May 01, 2026, 08:37 ET Researchers from Incheon National University Spotlight Next-Generation EV Diagnostics
multiple layers of information from the same vesicle, including proteins, RNA, lipids, and even physical properties such as stiffness." Such multi-omic profiling could provide a clearer picture of disease mechanisms and patient-specific risk.Looking ahead, the authors expect artificial intelligence
More news about: Incheon National University
Apr 29, 2026, 07:00 ET PreludeDx Receives FDA Breakthrough Device Designation for AidaBREAST® - Early-Stage Invasive Breast Cancer Assay
assessment and predicts the benefit of radiation therapy (RT) for women diagnosed with early-stage invasive breast cancer. The test integrates multi-omic data to generate a patient-specific assessment of 10-year locoregional recurrence risk and benefit from adjuvant radiation therapy, supporting more
More news about: Prelude Corporation
Apr 22, 2026, 09:00 ET Nature Reviews Drug Discovery | Target Identification and Assessment in the Era of AI
causal disease genes from genomic loci. Notable examples that Insilico Medicine has pioneered include the PandaOmics platform, which integrates multi-omic and published text data sources to nominate disease targets; GeroScope, which identifies potential targets implicated in aging from gene expression
More news about: Insilico Medicine
Apr 16, 2026, 08:00 ET Panome Bio and Audubon Bioscience Partner to Deliver End-to-End FFPE Biospecimen and Metabolomics Solutions for Cancer Researchers
Researchers interested in learning more about TissueBridge™ FFPE Metabolomics, the Audubon Bioscience partnership, or Panome Bio's full suite of multi-omic services are encouraged to visit Booth #2015 or contact the team at [email protected]
More news about: Panome Bio
Apr 16, 2026, 02:19 ET VTT-originated startup Proteins.1 launches to bring PCR-like amplification and simplicity to omics
how early disease can be caught."The global diagnostics market exceeds €100 billion annually, with growing demand for early detection and multi-omic analysis. Proteins.1 aims to establish a new category of ultra-sensitive protein diagnostics, combining high multiplexing, scalable chip-based detection,
More news about: VTT Info
Apr 15, 2026, 08:00 ET PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and consumer GLP-1 DNA test in H2 2026
these stratification tools to enhance clinical trial success and optimize treatment selection."The combination of Ovation's high-quality multi-omic and longitudinal clinical data and PrecisionLife's analytics platform has enabled us to rapidly expand understanding of the complex and heterogeneous
More news about: PrecisionLife Ltd
Apr 13, 2026, 08:30 ET Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology, Upcoming Webinar Hosted by Xtalks
morphologic evaluation into quantitative, reproducible data streams, enhancing consistency across global trials. AI-enabled digital pathology, multi-omic integration, and predictive modeling allow for quantitative disease characterization, earlier detection of therapeutic response or resistance, and improved
More news about: Xtalks
Apr 09, 2026, 20:00 ET AI Pioneer and Nobel Laureate Geoffrey Hinton Joins Human Longevity, Inc. Scientific Advisory Board
category-defining AI world model powered by one of the world's most comprehensive longitudinal datasets, integrating genomics, advanced imaging, and multi-omic biomarkers."We are deeply honored to welcome Dr. Hinton as an advisor to Human Longevity," said Dr. Wei-Wu He, Executive Chairman of HLI. "Artificial
More news about: Human Longevity Inc.
Apr 06, 2026, 11:00 ET DELFI Diagnostics to Showcase Whole-Genome cfDNA Platform Advances in Cancer Detection and Monitoring at AACR 2026 Annual Meeting
Molecular Response as an Early Indicator of Immunotherapy Outcomes in Lung CancerSession: Liquid Biopsy: Multi-Analyte and Multi-OmicPoster Section 5, Board 17 | Abstract #110Presenter: Jaime Wehr, MS, Johns Hopkins UniversityMonday, April 20 | 2:00–5:00
More news about: DELFI Diagnostics
Apr 03, 2026, 07:32 ET Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine's Future
University.Professor Jian Yang's research group is dedicated to developing statistical genetics and bioinformatics methods. By deeply analyzing genomic and multi-omic data from large-scale population cohorts, they aim to uncover the genetic architecture and molecular mechanisms underlying complex diseases, translating
More news about: Westlake University
Mar 31, 2026, 08:56 ET Breaking the PCR-Only Barrier: Dual 510(k) Clearance and CLIA-Waiver Establish FINDER as the First Molecular Point-of-Care Platform with Multifunctional Capabilities
first point-of-care heparin monitoring assay. Together, these milestones establish FINDER as a multifunctional platform."Call it multimodal, multi-omic, or multifunctional, we have a robust pipeline across assay types," said Vamsee Pamula, PhD, Founder and President of Baebies. "FINDER is designed
More news about: Baebies Inc.
Mar 25, 2026, 20:50 ET Human Longevity, Inc. and LEV Foundation Announce Strategic Collaboration to Decode Biological Drivers of Exceptional Longevity
information that may reveal why some individuals age more slowly and maintain health far longer than the general population. Through comprehensive multi-omic analysis including genomics and proteomics we will aim to identify key biomarkers and pathways associated with exceptional longevity.Building
More news about: Human Longevity, Inc.
Mar 17, 2026, 12:18 ET Sequential™ beschafft 3,5 Millionen Dollar für den Aufbau einer KI-gestützten Entdeckungsplattform für Multi-Omic-Tests und Hautpflege-Inhaltsstoffe der nächsten Generation
content:https://www.prnewswire.com/news-releases/sequential-beschafft-3-5-millionen-dollar-fur-den-aufbau-einer-ki-gestutzten-entdeckungsplattform-fur-multi-omic-tests-und-hautpflege-inhaltsstoffe-der-nachsten-generation-302716236.html
More news about: Sequential
Mar 17, 2026, 06:00 ET Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients
multimedia:https://www.prnewswire.com/news-releases/sequential-raises-3-5m-to-build-ai-powered-discovery-platform-for-multi-omic-testing-and-next-generation-skin-health-ingredients-302715280.htmlSOURCE
More news about: Sequential
Mar 17, 2026, 02:00 ET Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients
content:https://www.prnewswire.co.uk/news-releases/sequential-raises-3-5m-to-build-ai-powered-discovery-platform-for-multi-omic-testing-and-next-generation-skin-health-ingredients-302715284.html
More news about: Sequential